MBMargarita Andreevna Belotserkovskaya

Margarita Andreevna Belotserkovskaya


Margarita Andreevna Belotserkovskaya has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Dmitry Alekseevich Filimonov

    Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia

    5 shared publications
  • Irina Alexandrovna Kisilenko

    Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia

    3 shared publications
  • Viktor V. Turchin

    Laboratory of Cell and Tissue Cultivation, Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia

    3 shared publications
  • Andrey Gennadievich Popandopulo

    Laboratory of Cell and Tissue Cultivation, Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia

    2 shared publications
  • Kirill O. Golubitskiy

    Surgical Department No. 1, Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia

    2 shared publications
  • Maksim Vital'Evich Solopov

    Laboratory of Cell and Tissue Cultivation, Federal State Budgetary Institution “V.K. Gusak Institute of Emergency and Reconstructive Surgery” of the Ministry of Health of the Russian Federation, Donetsk 283045, Russia

    2 shared publications

Latest Publications

  • Open Access

    Methods of infected wounds’ modeling: in vitro, ex vivo, in vivo

    by R. V. Ishchenko, O. S. Antonyuk, D. A. Filimonov, K. O. Golubitskiy, M. A. Belotserkovskaya, D. V. Doroshilov, N. V. Tikunova, Р. В. Ищенко, О. С. Антонюк, Д. А. Филимонов, et al.

    Infected wounds are a severe medical problem that requires a comprehensive approach to diagnosis, treatment, and prevention. Adequate and modern model systems are needed for a study of the pathophysiology of wound infections, as well as for the development and testing of new therapeutic strategies. This review provides a comprehensive analysis of current models aimed at recreating the healing processes of infected skin wounds. The search for sources was conducted in the PubMed database using the keywords «infected wound», «model», « in vivo », « in vitro », and « ex vivo », excluding the words «burn» and «diabetic». The search depth was 22 years: from 2003 to 2025. A comparative study of in vitro , ex vivo , and in vivo  models has been conducted, including their methodological features, advantages, disadvantages, and translational effectiveness. Particular attention is paid to the analysis of each model in the context of reproducing the pathophysiological processes occurring in infected wounds. The result of the work is a comparative characteristic of the models, which makes it possible to assess their economic feasibility, deadlines, labor costs, complexity of implementation and reproducibility. To achieve more relevant and accurate results, the integration of data obtained in various model systems is promising.

  • Open Access

    Structural Analogues of Thyronamines. Computational 1H and 13C NMR Study of 4-[4-(2-Aminoetoxy)phenoxy]aniline—A New Structural Analogue of Thyronamines

    by Alexander B. Eresko, Elena V. Raksha, Dmitry A. Filimonov, Yuliya V. Berestneva, Nadezhda N. Trubnikova, Margarita A. Belotserkovskaya, Viktor V. Turchin, Roman V. Ishchenko

    Experimental and molecular modelling data on chemical shifts of 1H and 13C nuclei are presented for the 4-[4-(2-aminoethoxy)phenoxy]aniline (APA) dihydrochloride, which is a new structural analogue of thyronamine T0AM. In our study we treat two structural models of the APA—its protonated form [H-APA-H]2+ and neutral dihydrochloride APA·2HCl. Chemical shifts in the 1H and 13C nuclei were estimated for the basic conformers of [H-APA-H]2+ and APA·2HCl models. Nonspecific solvation with DMSO was taken into account within the polarized continuum model. Calculated chemical shifts in the 1H and 13C nuclei were in good agreement with the experimental ones obtained for 4-[4-(2-aminoethoxy)phenoxy]aniline dihydrochloride in DMSO-d6 solution.

  • Open Access

    Effect of a synthetic analogue of thyronamine on the levels of molecular markers of focal brain damage in an experimental model

    by Dmitry A. Filimonov, Nadezhda N. Trubnikova, Irina A. Kisilenko, Margarita A. Belotserkovskaya, Anzhelika A. Burtseva, Albina E. Glebova, Roman V. Ishchenko, Alexander B. Eresko, Elena V. Raksha, Dinara Sh. Diuba, et al.

    Introduction. Therapeutic options for ischemic stroke (IS) are largely limited to reperfusion, underscoring the importance of exploring new approaches to neuroprotection and neurorepair. Thyronamines — endogenous derivatives of thyroid hormones — are a promising class of compounds with putative neuroprotective potential. Study aim: To evaluate the effect of a synthetic thyronamine analog (SA-T0AM) on the levels of brain damage markers in a rat model of experimental IS. Materials and methods. The study was performed on 30 male Wistar rats divided into 4 groups: 1) Experimental — induction of focal cerebral cortical ischemia by application of ferric chloride followed by SA-T0AM administration; 2) Control — induction of ischemia without subsequent therapy; 3) Sham operation — all surgical manipulations except application of ferric chloride (0.9% NaCl solution was used); 4) intact animals. On day 3, concentrations of neuroglobin (NGB), glial fibrillary acidic protein (GFAP), brain-derived neurotrophic factor (BDNF), neuron-specific enolase (NSE), and S100B protein were determined in the cerebral hemisphere tissue by enzyme-linked immunosorbent assay (ELISA). Results. Induction of ischemia led to a significant increase in the levels of all studied damage biomarkers in both hemispheres. Surgical intervention (craniotomy) caused a nonspecific increase in GFAP, NSE, and BDNF in all operated groups compared to intact animals. The key difference between the Experimental and Control groups was found in the non-ischemic hemisphere: administration of SA-T0AM was associated with a statistically significant increase in NGB content. Conclusion. The observed selective increase in NGB levels in the contralateral hemisphere following SA-T0AM administration indicates the compound’s ability to activate endogenous neuroprotective mechanisms in response to ischemic injury. This effect may be indirect or it may represent an independent direct action of the agent on neuroglobin expression, which requires further investigation. Although no intergroup differences were found for other brain damage markers (GFAP, NSE, S100B), which may be due to insufficient model sensitivity, the data suggest that further study of SA-T0AM is warranted as a pharmacological postconditioning agent in cerebral ischemia.


  • Cell-specific expression of trace amine receptor 1 (TAAR1) in neurons across brain regions: transcriptome analysis using publicly available databases

    by D. A. Filimonov, M. Yu. Kotlovskiy, M. P. Potapov, M. A. Belotserkovskaya, A. G. Popandopulo, N. N. Trubnikova, I. A. Kisilenko, M. V. Solopov, V. V. Turchin

    Relevance. Trace amine-associated receptor-1 (TAAR1) mediates signaling through a broad spectrum of agonists that function as neuromodulators in classical neurotransmitter systems and may also potentially exert a neuroprotective effect. Objective. The aim of this study was to determine the expression pattern of TAAR1 in brain cells and tissues by analyzing publicly available gene expression databases. Materials and methods. TAAR1 gene expression was analyzed using datasets from the Allen Institute for Brain Science (Human Brain Atlas Microarray, Allen Brain Cell Atlas, Brain Allen Developing Human Brain Atlas, and Whole Mouse Brain Transcriptomic Cell Type Atlas). Results. Analysis of public transcriptomic databases revealed TAAR1 expression in the human cerebral cortex, amygdala, basal ganglia, hippocampus, and thalamus. Marked differences between human and mouse data indicate probable interspecies differences in TAAR1 expression. Conclusion. TAAR1 exhibits a heterogeneous and predominantly low-grade distribution within the central nervous system, highlighting the need for modern single-nucleus/single-cell sequencing methods and the development of in vivo approaches to receptor imaging.

  • Open Access

    Therapeutic effects of probiotics in topical treatment of infected wounds

    by Roman V. Ishchenko, Kirill O. Golubitskiy, Maksim Vital'Evich Solopov, Irina Alexandrovna Kisilenko, Margarita Andreevna Belotserkovskaya, Viktor V. Turchyn, Dmitry Alekseevich Filimonov, Andrey Gennadievich Popandopulo, Vagif Ali Ogly Gasanov

    Wound infections, exacerbated by antibiotic resistance and biofilm formation, necessitate alternative therapeutic options. One promising approach is topical bacteriotherapy with live probiotics. The work aimed to summarize existing research on the multifaceted effects of live probiotics in infected wound healing. The review examines how probiotics directly influence pathogenic wound microflora by competing for adhesion sites and nutrients, secreting antagonistic compounds, altering the wound environment, and promoting co-aggregation. Probiotics’ antibiofilm activity is highlighted, including inhibition of quorum sensing systems and disruption of the extracellular biofilm matrix. Moreover, the review discusses the findings of in vitro and in vivo studies on the effects of live probiotics on macroorganisms. Probiotics have been shown to activate signaling pathways that regulate macrophage shift from a pro-inflammatory (M1) phenotype to a pro-repair (M2) phenotype, cytokine synthesis, keratinocyte and fibroblast migration and proliferation, angiogenesis, and collagen matrix formation. Thus, the multifaceted effects of probiotics cannot be replicated by metabolites or inactivated cells alone, highlighting the need for effective delivery systems for live probiotic cultures in infected wound management.